2019 firm and individual rankings are now live
September 25, 2019
New content includes national firm rankings, life sciences stars and editorial reviews
US
General Patent Litigation
Hatch-Waxman Patent Litigation (Generic)
| Hatch-Waxman Patent Litigation (Generic) — Highly Recommended |
|---|
| Goodwin Procter |
| Knobbe Martens |
| Rakoczy Molino Mazzochi Siwik |
| Sterne Kessler Goldstein & Fox |
| Wilson Sonsini Goodrich & Rosati |
| Winston & Strawn |
| Hatch-Waxman Patent Litigation (Generic) — Recommended |
|---|
| Greenberg Traurig |
| Latham & Watkins |
| Morrison & Foerster |
| Perkins Coie |
| Robins Kaplan |
| Rothwell Figg Ernst & Manbeck |
| Taft Stettinius & Hollister |
| Willkie Farr & Gallagher |
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Klein, Charles | Intellectual Property | General Patent Litigation | Washington, D.C. |
| Lombardi, George C | Intellectual Property | Hatch-Waxman Patent Litigation | Chicago |
| Nutter, Michael K | Intellectual Property | Hatch-Waxman Patent Litigation | Chicago |
| Rurka, Maureen | Intellectual Property | Hatch-Waxman Patent Litigation | Chicago |
| Smerek, Stephen | Intellectual Property | Hatch-Waxman Patent Litigation | Los Angeles |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Intellectual Property
Winston & Strawn
Winston & Strawn's IP group is highly recommended in general patent and Hatch-Waxman litigation. The firm is most notable for being one of the most active generic practices in the Hatch-Waxman domain, and for its recent involvement acting for biosimilars clients in BPCIA disputes.
Litigation group co-chair George Lombardi is considered one of the foremost trial lawyers in the ANDA litigation area, a reputation bolstered by a significant year of patent work in the life sciences area. He currently represents Sandoz against Amgen entity Immunex in a biosimilars litigation related to marketed drug Enbrel. "I'd say the best of generic lawyers has got to be George Lombardi," a peer says. "He's been a frequent opponent over the years."
IP co-chair Charles Klein is another standout litigator in the firm's life sciences group, offering significant experience in Hatch-Waxman and biosimilars suits. About partner Maureen Rurka, a competitor says: "without a doubt I would [refer] something to Maureen and the group over at Winston." Another peer adds Rurka is a "highly competent, intuitive pharma patent litigator."
First-chair trial lawyer Michael Nutter focuses his practice full-time on life sciences matters. He acts as litigation counsel for the firm's many high-level generic clients, and is also involved in the growing area of BPCIA suits. Stephen Smerek has more than 20 years of practice in litigation, including significant Hatch-Waxman experience.
An up-and-comer in this space is Nimalka Wickramasekera, who was shortlisted by LMG Life Sciences for the Intellectual Property Rising Star award in 2019.
Articles
New content includes national firm rankings, life sciences stars and editorial reviews